Biosimilars

© GettyImages/ChooChin

UK market sees additional Herceptin biosimilar

By Jane Byrne

Accord Healthcare has announced the launch of a Herceptin biosimilar in the UK. Zercepac is the first monoclonal antibody (mAb) and fourth biosimilar launched by the company in Europe.

Follow us

Products

View more

Webinars